JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection
Sriprapun, Methee; Chuaypen, Natthaya; Khlaiphuengsin, Apichaya; Pinjaroen, Nutcha; Payungporn, Sunchai; Tangkijvanich, Pisit;
  PDF(new window)
 Abstract
Hepatocellular carcinoma (HCC) is major health problem with high mortality rates, especially in patients with hepatitis B virus (HBV) infection. Telomerase function is one of common mechanisms affecting genome stability and cancer development. Recent studies demonstrated that genetic polymorphisms of telomerase associated genes such as telomerase associated protein 1 (TEP1) rs1713449 and PIN2/TERF1-interacting telomerase inhibitor 1 (PINX1) rs1469557 may be associated with risk of HCC and other cancers. In this study, 325 patients with HCC and 539 non-HCC groups [193 healthy controls, 80 patients with HBV-related liver cirrhosis (LC) and 266 patients with HBV-related chronic hepatitis (CH)] were enrolled to explore genetic polymorphisms of both SNPs using the allelic discrimination method based on MGB probe TaqMan real time PCR. We demonstrated that all genotypes of both genes were in Hardy-Wienberg equilibrium (P>0.05). Moreover, there was no significant association between rs1713449 genotypes and HCC risk, HCC progression and overall survival (P>0.05). Interestingly, we observed positive association of rs1469557 with risk of HCC when compared with the LC group under dominant (CC versus CT+TT, OR
 Keywords
TEP1;PINX1;hepatocellular carcinoma;chronic hepatitis B virus;telomerase;polymorphism;
 Language
English
 Cited by
1.
CCR5 Polymorphism as a Protective Factor for Hepatocellular Carcinoma in Hepatitis B Virus-Infected Iranian Patients,;;;;

Asian Pacific Journal of Cancer Prevention, 2016. vol.17. 10, pp.4643-4646 crossref(new window)
 References
1.
Becker SA, Zhou YZ, Slagle BL (1996). Frequent loss of chromosome 8p in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res, 56, 5092-7.

2.
Bruix J, Sherman M (2005). Diagnosis of Small HCC. Gastroenterol, 129, 1364. crossref(new window)

3.
Cai MY, Zhang B, He WP, et al (2010). Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma. Cancer Sci, 101, 1543-9. crossref(new window)

4.
Chang J, Dinney CP, Huang M, et al (2012). Genetic variants in telomere-maintenance genes and bladder cancer risk. PLoS One, 7, 30665. crossref(new window)

5.
Chanthra N, Payungporn S, Chuaypen N, et al (2015). Association of Single Nucleotide Polymorphism rs1053004 in Signal Transducer and Activator of Transcription 3 (STAT3) with Susceptibility to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B. Asian Pac J Cancer Prev, 16, 5069-73. crossref(new window)

6.
Chemin I, Zoulim F (2009). Hepatitis B virus induced hepatocellular carcinoma. Cancer Lett, 286, 52-9. crossref(new window)

7.
Cong YS, Wright WE, Shay JW (2002). Human telomerase and its regulation. Microbiol Mol Biol Rev, 66, 407-25, table of contents. crossref(new window)

8.
Gu C, Li Q, Zhu Y, et al (2015). Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence. Prostate Cancer Prostatic Dis, 18, 310-6. crossref(new window)

9.
Hartmann D, Srivastava U, Thaler M, et al (2011). Telomerase gene mutations are associated with cirrhosis formation. Hepatol, 53, 1608-17. crossref(new window)

10.
Jung SW, Park NH, Shin JW, et al (2014). Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B. Hepatol, 59, 1912-20. crossref(new window)

11.
Llovet JM, Bru C, Bruix J (1999). Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis, 19, 329-38. crossref(new window)

12.
Shi M, Cao M, Song J, et al (2015). PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NFkappaB/MMP-9 signaling pathway. Mol Cancer, 14, 66. crossref(new window)

13.
Somboon K, Siramolpiwat S, Vilaichone RK (2014). Epidemiology and survival of hepatocellular carcinoma in the central region of Thailand. Asian Pac J Cancer Prev, 15, 3567-70. crossref(new window)

14.
Varadi V, Brendle A, Brandt A, et al (2009). Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis. Eur J Cancer, 45, 3008-16. crossref(new window)

15.
Yan L, Wu S, Zhang S, et al (2014). Genetic variants in telomerase reverse transcriptase (TERT) and telomeraseassociated protein 1 (TEP1) and the risk of male infertility. Gene, 534, 139-43. crossref(new window)

16.
Zhou XZ (2011). PinX1: a sought-after major tumor suppressor at human chromosome 8p23. Oncotarget, 2, 810-9. crossref(new window)